Table 1 Characteristics of the patients
Variable | Value | Range |
|---|---|---|
Age a | 74.2 yr (±8.8) | 47-96 |
Disease onset age a | 66.8 yr (±10.1) | 35-88 |
Duration of disease a | 7.6 yr (±5.9) | 1-35 |
HY ≥3, n (%) | 164 (62.6 %) | |
SE-ADL ≤75 %, n (%) | 139 (53.3 %) | |
MMSE ≥25, n (%) | 197 (76.7 %) | |
BDI ≥14, n (%) | 134 (52.1 %) | |
MDS-UPDRS | ||
MDS-UPDRS Part I | 12.52 (6.79) | 0-38 |
MDS-UPDRS Part II | 18.2 (8.4) | 1-48 |
MDS-UPDRS Part III | 46.3 (18.3) | 10-106 |
MDS-UPDRS Part IV | 1.3 (3.4) | 0-18 |
Clinical subtypes | ||
Tremor dominant | 118 (44 %) | |
Hypokinetic-rigid dominant | 77 (28.7 %) | |
Postural instability and gait disturbance dominant | 73 (27.3 %) | |
Levodopa equivalent dose per day a | 427.5 mg (±231.6) | 100-1200 |
Duration of levodopa treatment a | 3.9 yr (±5.03) | 0.1-23 |
Marital status, n (%) | ||
Single | 20 (7.4 %) | |
Married | 128 (47.8 %) | |
Divorced | 23 (8.6 %) | |
Widowed | 97 (36.2 %) | |
Living status, n (%) | ||
With a spouse | 137 (51,1 %) | |
With children | 55 (20,5 %) | |
Alone | 66 (24.6 %) | |
Nursery home | 10 (3.8 %) | |
Education, n (%) | ||
Primary | ||
Secondary | 104 (38.8 %) | |
Higher | 95 (35.5 %) | |
69 (25.7 %) |